International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 3 , Pages 692-698, 1 March 2009

Prediction of Intrafraction Prostate Motion: Accuracy of Pre- and Post-Treatment Imaging and Intermittent Imaging

  • Camille Noel, B.S.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
  • ,
  • Parag J. Parikh, M.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • Corresponding Author InformationReprint requests to: Parag J. Parikh, M.D., Department of Radiation Oncology, Washington University School of Medicine, 4921 Parkview Place, Lower Level, St. Louis, MO 63110. Tel: (314) 362-8525; Fax: (314) 362-8521
  • ,
  • Meghana Roy, B.A.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
  • ,
  • Patrick Kupelian, M.D.

      Affiliations

    • M.D. Anderson Cancer Center, Orlando, FL
  • ,
  • Arul Mahadevan, M.D.

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
  • ,
  • Geoffrey Weinstein, M.D.

      Affiliations

    • Sharp Memorial Hospital, San Diego, CA
  • ,
  • Charles Enke, M.D.

      Affiliations

    • Nebraska Medical Center, Omaha, NE
  • ,
  • Nicholas Flores, M.D.

      Affiliations

    • Arizona Oncology Services, Scottsdale, AZ
  • ,
  • David Beyer, M.D.

      Affiliations

    • Nebraska Medical Center, Omaha, NE
  • ,
  • Lisa Levine, Ph.D.

      Affiliations

    • Calypso Medical Technologies, Seattle, WA

Received 19 December 2007; received in revised form 22 April 2008; accepted 25 April 2008. published online 08 August 2008.

Purpose

To evaluate whether pre- and post-treatment imaging (immediately before and after a radiation therapy treatment fraction) and intermittent imaging (at intervals during a treatment fraction) are accurate predictors of prostate motion during the delivery of radiation.

Methods and Materials

The Calypso 4D Localization System was used to continuously track the prostate during radiation delivery in 35 prostate cancer patients, for a total of 1,157 fractions (28–45 per patient). Predictions of prostate motion away from isocenter were modeled for a pre- and post-treatment imaging schedule and for multiple intermittent intrafraction imaging schedules and compared with the actual continuous tracking data. The endpoint was drift of the prostate beyond a certain radial displacement for a duration of more than 30 s, 1 min, and 2 min. Results were used to evaluate the sensitivity and specificity of these models as an evaluation of intrafraction prostate motion.

Results

The sensitivity of pre- and post-treatment imaging in determining 30 s of intrafraction prostate motion greater than 3, 5, or 7 mm for all fractions was low, with values of 53%, 49%, and 39%, respectively. The specificity of pre- and post-treatment imaging was high for all displacements. The sensitivity of intermittent imaging improved with increasing sampling rate.

Conclusions

These results suggest that pre- and post-treatment imaging is not a sensitive method of assessing intrafraction prostate motion, and that intermittent imaging is sufficiently sensitive only at a high sampling rate. These findings support the value of continuous, real-time tracking in prostate cancer radiation therapy.

Organ motion, Prostate cancer, Radiation therapy, Target localization, Tracking

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Oct 28-Nov 1, 2007, Los Angeles, CA.

 Conflict of interest: Lisa Levine, Ph.D., is an employee of Calypso® Medical Technologies.

PII: S0360-3016(08)00826-2

doi:10.1016/j.ijrobp.2008.04.076

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 3 , Pages 692-698, 1 March 2009